EMBC vs SGEN
Embecta Corp (EMBC) versus SGEN (SGEN) — a side-by-side from cached financials, not a winner call.
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
SGEN (SGEN) common stock.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
SGEN does not have a complete income-statement cache yet.
EMBC currently screens at market cap $609.6M and trailing P/E 11.7.
Not investment advice. Open the EMBC and SGEN stock pages for the full models.
Not investment advice.